These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 2280995

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The relationship between anti-human eye muscle antibodies and thyroid function, anti-TSH receptor antibodies and eye symptoms in Graves' ophthalmopathy.
    Molnár I, Balázs C.
    Wien Klin Wochenschr; 1992; 104(24):744-7. PubMed ID: 1363165
    [Abstract] [Full Text] [Related]

  • 5. Extraocular muscle antibodies and the occurrence of ophthalmopathy in Graves' disease.
    de Bellis A, Perrino S, Coronella C, Sansone D, Ruocco G, Tirelli G, Di Martino S, Conte M, Bellastella G, Wall JR, Bellastella A, Bizzarro A.
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):694-8. PubMed ID: 15163332
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A thyroid cytotoxic antibody that cross-reacts with an eye muscle cell surface antigen may be the cause of thyroid-associated ophthalmopathy.
    Hiromatsu Y, Fukazawa H, Guinard F, Salvi M, How J, Wall JR.
    J Clin Endocrinol Metab; 1988 Sep; 67(3):565-70. PubMed ID: 3410941
    [Abstract] [Full Text] [Related]

  • 8. Prevalence and significance of antibodies reactive with eye muscle membrane antigens in sera from patients with Graves' ophthalmopathy and other thyroid and nonthyroid diseases.
    Wu YJ, Clarke EM, Shepherd P.
    Thyroid; 1998 Feb; 8(2):167-74. PubMed ID: 9510126
    [Abstract] [Full Text] [Related]

  • 9. Study of serum antibodies against three eye muscle antigens and the connective tissue antigen collagen XIII in patients with Graves' disease with and without ophthalmopathy: correlation with clinical features.
    Gopinath B, Musselman R, Adams CL, Tani J, Beard N, Wall JR.
    Thyroid; 2006 Oct; 16(10):967-74. PubMed ID: 17042681
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Leukocyte migration test for the study of immune reactivity in cases of Graves disease associated with infiltrative ophthalmopathy.
    Kálmán K, Erdei I, Sándor P, Fazakas S, Leövey A.
    Acta Med Acad Sci Hung; 1978 Oct; 35(1):29-34. PubMed ID: 581631
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Muscle antigens recognized with autoantibodies in patients with Graves' ophthalmopathy].
    Adler G.
    Endokrynol Pol; 1992 Oct; 43(1 Suppl):1-61. PubMed ID: 1345558
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Prevalence of antibodies reactive with a 64 kDa eye muscle membrane antigen in thyroid-associated ophthalmopathy.
    Salvi M, Bernard N, Miller A, Zhang ZG, Gardini E, Wall JR.
    Thyroid; 1991 Oct; 1(3):207-13. PubMed ID: 1824337
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.